NL-OMON21147尚未招募不适用
A double blind, placebo controlled Phase 2 study comparing the effects ofARA 290 on neuropathic symptoms of patients with type 2 diabetes.
eiden University Medical Center0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Established diagnosis of diabetes mellitus type 2;
- •2. Screening HbA1c between 7.5 % and 10 % inclusive;
排除标准
- •1. Clinically relevant abnormal history of physical and mental health other than conditions related to diabetes, as determined by medical history taking (as judged by the investigator);
- •2. Clinically relevant abnormal laboratory results, vital signs, or physical findings other than conditions related to diabetes (as judged by the investigator);
研究者
相似试验
进行中（未招募）
不适用
A study the effects of ARA 290 administered subcutaneously on nerve disease in patients with type 2 diabetesDiabetes type 2: neuropathic symptomsEUCTR2012-005590-32-NLeiden University Medical Center
进行中（未招募）
不适用
The effect of a novel drug (CCX140-B) on albuminuria in patients with type 2 diabetes mellitusType 2 Diabetes Mellitus, nephropathy, albuminuriaMedDRA version: 14.0Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.0Level: PTClassification code 10027525Term: MicroalbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.0Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-003049-16-NLChemoCentryx, Inc
已完成
2 期
A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Effect of CCX140-B on Albuminuria in Subjects with Type 2 Diabetes Mellitusalbuminuriaprotein in urine1001265310029149NL-OMON38004Chemocentryx24
进行中（未招募）
不适用
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseMedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-002563-23-LTMedImmune Limited300
进行中（未招募）
不适用
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted.Chronic Obstructive Pulmonary DiseaseMedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855EUCTR2011-002563-23-PLMedImmune Limited300